| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159420 | The Journal of Urology | 2012 | 7 Pages |
Abstract
Induction gemcitabine and carboplatin for nonorgan confined urothelial carcinoma achieves clinical and pathological response rates, and survival outcomes comparable to those of the cisplatin based combination chemotherapy schemes. Our data suggest that a carboplatin based regimen can be considered a reasonable alternative for cisplatin unfit patients in the preoperative setting.
Keywords
CCRmethotrexate, vinblastine, doxorubicin and cisplatinMVACgemcitabine and cisplatinRFSDSSDisease specific survivalRecurrence-free survivaloverall survivalcomputerized tomographyUrinary bladder neoplasmsurothelial carcinomacisplatinRadical cystectomyUrinary bladderPCRPathological complete responseclinical complete responseCarboplatinLymph nodeUrothelium
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Laura S. Mertens, Richard P. Meijer, J. Martijn Kerst, Andries M. Bergman, Harm van Tinteren, Bas W.G. van Rhijn, Simon Horenblas,